Related Experiment Video
Updated: Jun 22, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Molecular biology of infectious agents in chronic arthritis
Hervé C Gérard1, Judith A Whittum-Hudson, John D Carter
1Department of Immunology and Microbiology, Wayne State University School of Medicine, 540 East Canfield Avenue, Detroit, MI 48201, USA. ahudson@med.wayne.edu
Abstract:
Severe and chronic inflammatory arthritis sometimes follows urogenital infection with Chlamydia trachomatis or gastrointestinal infection with enteric bacterial pathogens. A similar clinical entity can be elicited by the respiratory pathogen Chlamydophila (Chlamydia) pneumoniae. Arthritogenesis does not universally require viable enteric bacteria in the joint. In arthritis induced by either of the chlamydial species, organisms are viable and metabolically active in the synovium. They exist in a "persistent" state of infection. Conventional antibiotic treatment of patients with Chlamydia-induced arthritis is largely ineffective. The authors outline the current understanding of the molecular genetic and biologic aspects underlying bacterially-induced joint pathogenesis, available information regarding host-pathogen interaction at that site, and several directions for future study to inform development of more effective therapies.
Insights
Chronic inflammatory arthritis can follow infections with Chlamydia trachomatis or Chlamydophila pneumoniae. These bacteria persist in joints, making standard antibiotic treatments for Chlamydia-induced arthritis ineffective.
Area of Science:
- Microbiology
- Immunology
- Rheumatology
Background:
- Inflammatory arthritis can arise after infections with Chlamydia trachomatis (urogenital) or Chlamydophila pneumoniae (respiratory).
- Arthritis pathogenesis does not always require viable enteric bacteria within the joint.
- Chlamydial species remain viable and metabolically active in the synovium, indicating a persistent infection state.
Purpose of the Study:
- To review the molecular and biological mechanisms of bacterial-induced joint pathogenesis.
- To summarize host-pathogen interactions at the joint site in Chlamydia-induced arthritis.
- To identify future research directions for improved therapeutic strategies.
Main Methods:
- Review of existing literature on Chlamydia-induced arthritis.
- Analysis of molecular genetic and biological aspects of pathogenesis.
- Examination of host-pathogen interactions in the synovium.
Main Results:
- Chlamydial species are viable and metabolically active within the joint synovium during persistent infection.
- Conventional antibiotic therapies are largely ineffective for treating Chlamydia-induced arthritis.
- Understanding of bacterial persistence and host response is crucial for therapeutic development.
Conclusions:
- Chlamydia-induced arthritis involves persistent bacterial infection within the joint.
- Current antibiotic treatments are insufficient for Chlamydia-induced arthritis.
- Further research into host-pathogen interactions and bacterial persistence is needed to develop effective therapies.
Related Concept Videos
Chronic Inflammation: Introduction
Bacterial Meningitis II: Pathophysiology
The JAK-STAT Signaling Pathway
Inflammatory Bowel Disease III: Crohn's Disease
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...